The SP Angel Healthcare Team represents clients from across the industry, including companies at the forefront of biotechnology, pharmaceuticals, medical devices, digital health and healthcare services. Our team has established a solid reputation in helping clients secure private and public funding at every stage of their journey, from preclinical work to commercialisation, and sale/acquisition.

In addition to fundraising and public offerings, the Team provides advisory services on M&A transactions, due diligence, valuation, financial modelling and equity research. Further, SP Angel advises clients on multiple markets, including AIM, the Aquis Exchange and the Standard List.

Our research analysts are skilled in identifying and communicating investment ideas to both the generalist and specialist investor communities. This technical expertise is supported by a specialised sales and broking team with proven experience in funding healthcare companies at all stages of development, including via private capital raises, IPOs and secondary fundraises. Finally, an experienced corporate finance team ensures we provide our clients with the regulatory and strategic guidance required to deliver results in the highly regulated fields of finance and healthcare.